54Gene - Series B $45,000,000 | All Business Africa

Series B BioTech

$45M

Nigeria October 2021 West Africa

About this Deal

54gene raised $45M Series B for African genomics before closing in 2023.

Investors

Undisclosed investors

Deal Details

Amount$45M

TypeSeries B

InstrumentEquity

SectorBioTech

FounderMale-led

StatusClosed

Other Companies in this Market

See all

Innoson Group Made in Nigeria, made for Africa

Oando PLC Energy for Africa

EbonyLife Media Africa's premier media company

Julius Berger Nigeria Building Nigeria since 1965

Onitsha Main Market Traders Association Africa's largest market

Aluko & Oyebode Nigeria's premier law firm

People in this Space

See all

Oluwole Rasheed Sarumi Founder @ Saroafrica International

Reni Folawiyo Founder @ Alara Lagos

Nike Davies-Okundaye Founder @ Nike Art Gallery

Bolanle Austen-Peters Founder @ Terra Kulture

Mira Mehta Founder @ Tomato Jos

Kola Masha Founder @ Babban Gona

Related News

See all

Stop Calling Them Neobanks: The Pan-African Retail Bank Has Arrived Kuda is now a nationally licensed Nigerian bank. FairMoney is a licensed microfinance bank with curr...

Why Nigeria's Open Banking Framework Will Underperform Its Promise Nigeria became the first African country to go live with formal open banking on 1 August 2025. The C...

African Wealthtech Needs to Admit It Is a Currency Hedge, Not a Wealth Builder PiggyVest has over 7 million users. Cowrywise passed 800,000. Bamboo and Risevest have built credibl...

How to Price and Structure B2B Supply Chain Finance in African Markets B2B supply chain finance is one of the most promising African fintech categories because it addresse...